You have accessJournal of UrologyStem Cell Research1 Apr 2011181 CELL THERAPY WITH AUTOLOGOUS URINE-DERIVED STEM CELLS FOR VESICOURETERAL REFLUX Shaofeng Wu, GuiHua Liu, Shantaram Bharadwaj, Steve Hoagie, Anthony Atala, and Yuanyuan Zhang Shaofeng WuShaofeng Wu Winston-Salem, NC More articles by this author , GuiHua LiuGuiHua Liu Winston-Salem, NC More articles by this author , Shantaram BharadwajShantaram Bharadwaj Winston-Salem, NC More articles by this author , Steve HoagieSteve Hoagie Winston-Salem, NC More articles by this author , Anthony AtalaAnthony Atala Winston-Salem, NC More articles by this author , and Yuanyuan ZhangYuanyuan Zhang Winston-Salem, NC More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.250AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES As an alternative to bulking agents, endoscopic injections of autologous cells have been used to restore the normal structure and function of the vesicoureteral junction. Vascularization of the injected graft is critical for enhancement of cell survival and maintenance of the volume of the graft. Recently, we have demonstrated that certain cells in urine possess the characteristics of stem cells, including extensive expansion capability and multipotency. The goal of this study was to evaluate the effect of vascular endothelial growth factor (VEGF) over-expression on urine-derived stem cell (USC) survival, growth and myogenic differentiation and to determine whether this technique could improve injection therapy for the correction of VUR. METHODS USC were obtained from 9 urine samples (5 healthy individual donors; ages 3 to 27). USC were infected with adenovirus containing the human VEGF gene (USC/Ad-VEGF). USC/Ad-VEGF plus endothelial cells (in total 5×106 cells) in 500μl collagen-I gel were subcutaneously implanted into 20 athymic mice. After 28 days, the grafts were assessed grossly and with histology and immunocytochemistry for smooth muscle markers (α-smooth muscle actin, desmin and myosin) endothelial markers (CD 31 and von Willeband factor) and peripheral nerve cell markers (S-100, neurofilament, glial fibrillary acidic protein). RESULTS The grafts containing both USC/Ad-VEGF and endothelial cells were larger and better vascularized compared to non-VEGF expressing controls. Additionally, the total number of implanted cells expressing human nuclear markers was significantly higher, indicating increased cell survival in the VEGF-expressing grafts. More VEGF-expressing cells expressed CD31 and von Willebrand proteins, as well as smooth muscle markers. Interestingly, more nerve fibers and revascularization appeared in the USC/Ad-VEGF plus endothelial cells group than the controls in vivo. However, the regenerated nerve cells did not stain for human nuclear protein expression, indicating that these regenerated nerve fibers most likely originated from mouse peripheral nerve rather than from the differentiation of USC. CONCLUSIONS VEGF over-expression in grafted USC enhanced the in vivo survival of these cells and increased neovascularization, myogenic differentiation of USC, and nerve regeneration within the grafts. This approach might have important clinical implications for urological cell therapy for the treatment of VUR and urinary incontinence. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e75 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Shaofeng Wu Winston-Salem, NC More articles by this author GuiHua Liu Winston-Salem, NC More articles by this author Shantaram Bharadwaj Winston-Salem, NC More articles by this author Steve Hoagie Winston-Salem, NC More articles by this author Anthony Atala Winston-Salem, NC More articles by this author Yuanyuan Zhang Winston-Salem, NC More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...